89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study

Conditions:   Breast Cancer;   Metastatic Breast Cancer;   HER2-positive Breast Cancer;   Gastric Cancer;   Metastatic Gastric Cancer;   HER2-positive Gastric Cancer Intervention:   Diagnostic Test: 89Zr-DFO*-trastuzumab PET scan Sponsors:   Amsterdam UMC, location VUmc;   AstraZeneca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials